Home/Filings/4/0001567619-19-016174
4//SEC Filing

Thornton Peter J. 4

Accession 0001567619-19-016174

CIK 0001012477other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 5:05 PM ET

Size

8.1 KB

Accession

0001567619-19-016174

Insider Transaction Report

Form 4
Period: 2019-08-07
Transactions
  • Award

    Stock Option (right to buy)

    2019-08-07+60,00060,000 total
    Exercise: $2.03Exp: 2029-08-07ADSs (60,000 underlying)
Holdings
  • ADSs

    33,055
  • Stock Option (right to buy)

    Exercise: $10.51From: 2018-06-28Exp: 2022-06-28ADSs (35,000 underlying)
    35,000
Footnotes (4)
  • [F1]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
  • [F2]Includes 27,900 restricted ADSs granted under the issuer's Omnibus Incentive Compensation Plan on 08/01/2018; one-third (1/3) of the ADSs will vest on each of the first three anniversaries of the grant date.
  • [F3]Options become exercisable as to all 35,000 ADSs on the first anniversary of the 06/28/2017 grant date.
  • [F4]Options become exercisable as to 20,000 ADSs on each of the first three anniversaries after the 08/07/2019 grant date.

Documents

1 file

Issuer

AVADEL PHARMACEUTICALS PLC

CIK 0001012477

Entity typeother

Related Parties

1
  • filerCIK 0001295432

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 5:05 PM ET
Size
8.1 KB